Global Hormonal Contraceptive Market, By Product (Combined Oral Contraceptives, Oral, Contraceptives, Implanted Contraceptives, Injected Contraceptives, Intrauterine, Trasdermal Patch Vaginal Ring), Hormone (Androgens, Estrogens, Progestogens, Antiandrogens, Gonadotropins, Others), Age Group (15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years), Gender (Male and Female), End-User (Hospitals, Homecare, Clinics, Gynecology Centers, Ambulatory Surgical Centers (ASC)), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The hormonal contraceptive market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 4.75% in the forecast period of 2021 to 2028. The growing of user awareness will help in escalating the growth of the healthcare analytical testing services market.
Hormonal contraceptives are birth control methods, which act on the endocrine system. These methods comprise the use of hormones that are produced normally by women, like estrogen and progesterone, to avoid ovulation and in turn pregnancy. Yet, they do not offer protection against HIV or other sexually transmitted infections.
Major factors that expected to boost the growth of the hormonal contraceptive market in the forecast period rise in the attention towards the family planning, the demand for avoiding unintended pregnancy and the advancement in the hormonal contraception with enhanced efficiency and fewer side effects. Furthermore, the health concerns related with teenage pregnancies, rise in the awareness towards the modern contraception methods and the increase in the utilization of oral pills are further anticipated to propel the growth of the hormonal contraceptive market.
On the other hand, the obtainability of substitute contraceptive methods, the risks related to health due to the utilization of contraceptives and the absence of social acceptance favourably are further estimated to impede the growth of the hormonal contraceptive market in the near future.
This hormonal contraceptive market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hormonal contraceptive market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Hormonal Contraceptive Market Scope and Market Size
The hormonal contraceptive market is segmented on the basis of product, hormone, age group, gender and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the hormonal contraceptive market is segmented into combined oral contraceptives, oral, contraceptives, implanted contraceptives, injected contraceptives, intrauterine, transdermal patch, vaginal ring.
- On the basis of hormone, the hormonal contraceptive market is segmented into androgens, estrogens, progestogens, antiandrogens, gonadotropins, others.
- On the basis of age group, the hormonal contraceptive market is segmented into 15-24 years, 25-34 years, 35-44 years, above 44 years),
- On the basis of gender, the hormonal contraceptive market is segmented into male and female.
- On the basis of end user, the hormonal contraceptive market is segmented into hospitals, homecare, clinics, gynecology centers, ambulatory surgical centers (ASC).
Hormonal Contraceptive Market Country Level Analysis
The hormonal contraceptive market is analysed and market size insights and trends are provided by country, product, hormone, age group, gender and end user as referenced above.
The countries covered in the hormonal contraceptive market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the hormonal contraceptive market due to the increase in the per capita income and the strong occurrence of key market players. Furthermore, the increase in the consciousness concerning the sexual health and the growing numbers of accidental pregnancies. Asia Pacific is projected to observe significant amount of growth in the hormonal contraceptive market due to the large fertile population and introduction of new female contraception devices. Moreover, the increase in the investment by market players and strong economic growth is further anticipated to propel the growth of the hormonal contraceptive market in the region in the coming years.
The country section of the hormonal contraceptive market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The hormonal contraceptive market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hormonal contraceptive market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hormonal contraceptive market. The data is available for historic period 2010-2019.
Competitive Landscape and Hormonal Contraceptive Market Share Analysis
The hormonal contraceptive market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hormonal contraceptive market.
The major players covered in the hormonal contraceptive market report are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Piramal Enterprises, Pfizer, Inc., Novartis AG, Lupin Pharmaceuticals, Inc., Glenmark Pharmaceuticals, Cipla Inc., Bayer AG, Amgen Inc., HLL Lifecare, Merck & Co., Inc., Afaxys, Inc, Agile Technologies, Inc., Reckitt Benckiser Group plc., Boehringer Ingelheim International GmbH., V-Care Pharma Pvt. Ltd., Apothecus Inc., ANI Pharmaceuticals, Inc., Warner Chilcott, Allergan plc, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Hormonal Contraceptive Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.